Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.65 |
| ▸ | ESR1 | P03372 | 4/20 | 0.61 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.54 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.52 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.48 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.48 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | LPL | P06858 | 1/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29772972 | 1.00 | CYP2A6 (0.65) | CYP2A6ESR1ESR2ALDH1A1MAPK1 | |
| SCHEMBL29362228 | 1.00 | CYP2A6 (0.65) | CYP2A6ESR1ESR2ALDH1A1MAPK1 | |
| SCHEMBL2518014 | 1.00 | CYP2A6 (0.65) | CYP2A6ESR1ESR2ALDH1A1MAPK1 | |
| SCHEMBL31481607 | 1.00 | CYP2A6 (0.65) | CYP2A6ESR1ESR2ALDH1A1MAPK1 | |
| SCHEMBL28527548 | 1.00 | CYP2A6 (0.65) | CYP2A6ESR1ESR2ALDH1A1MAPK1 | |
| Anthracene SCHEMBL28888145 | 0.98 | CYP2A6 (0.62) | CYP2A6ESR1ESR2ALDH1A1MAPK1 | |
| SCHEMBL25235997 | 0.94 | CYP2A6 (0.58) | CYP2A6ESR1ESR2ALDH1A1MAPK1 | |
| SCHEMBL12192925 | 0.93 | CYP2A6 (0.77) | CYP2A6ESR1ESR2ALDH1A1MAPK1 | |
| SCHEMBL28392418 | 0.93 | CYP2A6 (0.56) | CYP2A6ESR1ESR2ALDH1A1MAPK1 | |
| SCHEMBL2512052 | 0.91 | ALDH1A1 (0.71) | CYP2A6ESR1ESR2ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 722 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102516014-B | Anthracene derivative with asymmetric molecular structure and its preparation method and use | JILIN OLED OPTICAL AND ELECTRONIC MATERIALS CO LTD | 2014-05-14 | — | — | CN | claimed |
| CN-102516014-A | Anthracene derivative with asymmetric molecular structure and its preparation method and use | JILIN OLED OPTICAL AND ELECTRONIC MATERIALS CO LTD | 2012-06-27 | — | — | CN | claimed |
| US-12635408-B2 | Organic electroluminescence device and amine compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| EP-4729506-A1 | LIGHT EMITTING ELEMENT, MONOAMINE COMPOUND FOR THE LIGHT EMITTING ELEMENT, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT EMITTING ELEMENT | Samsung Display Co., Ltd. (KR) | 2026-04-22 | — | — | EP | disclosed |
| US-20260107630-A1 | LIGHT EMITTING ELEMENT, MONOAMINE COMPOUND FOR THE LIGHT EMITTING ELEMENT, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT EMITTING ELEMENT | SAMSUNG DISPLAY CO LTD (KR) | 2026-04-16 | — | — | US | disclosed |
| US-12590076-B2 | Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2026-03-31 | — | — | US | disclosed |
| US-12588407-B2 | Organic light-emitting element | LG CHEM, LTD. (KR) | 2026-03-24 | — | — | US | disclosed |
| US-12588408-B2 | Light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2026-03-24 | — | — | US | disclosed |
| EP-4692058-A1 | ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | Hodogaya Chemical Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12532660-B2 | Light emitting device and amine compound for the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-01-20 | — | — | US | disclosed |
| US-12514118-B2 | Heterocyclic compound, organic light emitting device comprising the same, method for manufacturing the same and composition for organic material layer of organic light emitting device | LT MATERIALS CO., LTD. (KR) | 2025-12-30 | — | — | US | disclosed |
| EP-1333018-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2003-08-06 | — | — | EP | disclosed |
| EP-0801644-A4 | POLYARYLCARBAMOYLAZA -AND- CARBAMOYLALKANEDIOIC ACIDS | RHONE POULENC RORER PHARMA (US) | 2001-03-07 | — | — | EP | disclosed |
| US-5712396-A | PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS | MAGNIN DAVID R (US) | 1998-01-27 | — | — | US | disclosed |
| EP-0801644-A1 | POLYARYLCARBAMOYLAZA -AND- CARBAMOYLALKANEDIOIC ACIDS | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1997-10-22 | — | — | EP | disclosed |
| US-5567841-A | ANTICHOLESTEROL AGENT | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-10-22 | — | — | US | disclosed |
| US-5556990-A | SQUALENE SYNTHASE INHIBITORS, ANTICHOLESTEROL AGENTS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1996-09-17 | — | — | US | disclosed |
| WO-1996018615-A1 | POLYARYLCARBAMOYLAZA -AND- CARBAMOYLALKANEDIOIC ACIDS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1996-06-20 | — | — | WO | disclosed |
| US-5470845-A | Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-11-28 | — | — | US | disclosed |
| EP-0595635-A1 | Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors | E.R. Squibb & Sons, Inc. (US) | 1994-05-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12532660-B2 | Light emitting device and amine compound for the same | ARL1, CRY1, RFT1 | CYP2A6 1173/4885ESR1 62/4885ESR2 44/4885 |
| US-12588407-B2 | Organic light-emitting element | LAS1L, LEF1, ARL1 | CYP2A6 2105/4885ESR1 74/4885ESR2 48/4885 |
| US-20260107630-A1 | LIGHT EMITTING ELEMENT, MONOAMINE COMPOUND FOR THE LIGHT EMITTING ELEMENT, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT EMITTING ELEMENT | SLC18A1, SLC6A2, SLC18A2 | CYP2A6 429/4885ESR1 137/4885ESR2 152/4885 |
| US-12514118-B2 | Heterocyclic compound, organic light emitting device comprising the same, method for manufacturing the same and composition for organic material layer of organic light emitting device | C1R, CBR3, CBR1 | CYP2A6 1159/4885ESR1 304/4885ESR2 287/4885 |
| US-12635408-B2 | Organic electroluminescence device and amine compound for organic electroluminescence device | LEF1, MLLT1, NAP1L1 | CYP2A6 3225/4885ESR1 209/4885ESR2 160/4885 |
| US-12588408-B2 | Light-emitting element, light-emitting device, electronic device, and lighting device | CYBA, AHR, SUN2 | CYP2A6 145/4885ESR1 5/4885ESR2 100/4885 |
| US-12590076-B2 | Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device | ESR1, LEF1, AR | CYP2A6 2269/4885ESR1 1/4885ESR2 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.